866-997-4948(US-Canada Toll Free)

Asia-Pacific Anti-Cancer Injectable Market Report 2017

Published By :

QYResearch

Published Date : Apr 2017

Category :

Pharmaceutical

No. of Pages : 123 Pages

In this report, the Asia-Pacific Anti-Cancer Injectable market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (Million Units), revenue (Million USD), market share and growth rate of Anti-Cancer Injectable for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Anti-Cancer Injectable market competition by top manufacturers/players, with Anti-Cancer Injectable sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Eli Lilly
Chiron
Celgene Inc
Ferring Pharmaceuticals
Johnson & Johnson
Jazz Pharmaceuticals
Spectrum Pharmaceuticals
Takeda Pharmaceuticals
Genzyme
GSK
Sandoz
Pharmascience
Admac Lifesciences
Fresenius Kabi Oncology Limited
Jiangsu Hengrui Medicine
Nanjing Cisco Pharmaceuticals
Jiangsu Hengrui Medicine
Shanghai Roche
Jiangsu Haosen Pharmaceutical
F Hoffmann-La Roche Ltd (SW)
France Masi Pu (China) Pharmaceuticals

On the basis of product, this report displays the sales volume (Million Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Chemical Medicine Injectable
Traditional Chinese Medicine Injectable

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (Million Units), market share and growth rate of Anti-Cancer Injectable for each application, includin
Hospital
Clinic
Other

Table of Contents

Asia-Pacific Anti-Cancer Injectable Market Report 2017
1 Anti-Cancer Injectable Overview
1.1 Product Overview and Scope of Anti-Cancer Injectable
1.2 Classification of Anti-Cancer Injectable by Product Category
1.2.1 Asia-Pacific Anti-Cancer Injectable Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Anti-Cancer Injectable Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Chemical Medicine Injectable
1.2.4 Traditional Chinese Medicine Injectable
1.3 Asia-Pacific Anti-Cancer Injectable Market by Application/End Users
1.3.1 Asia-Pacific Anti-Cancer Injectable Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Asia-Pacific Anti-Cancer Injectable Market by Region
1.4.1 Asia-Pacific Anti-Cancer Injectable Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Anti-Cancer Injectable (2012-2022)
1.5.1 Asia-Pacific Anti-Cancer Injectable Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Anti-Cancer Injectable Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Anti-Cancer Injectable Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Anti-Cancer Injectable Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Anti-Cancer Injectable Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Anti-Cancer Injectable Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Anti-Cancer Injectable (Volume and Value) by Type
2.2.1 Asia-Pacific Anti-Cancer Injectable Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Anti-Cancer Injectable Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Anti-Cancer Injectable (Volume) by Application
2.4 Asia-Pacific Anti-Cancer Injectable (Volume and Value) by Region
2.4.1 Asia-Pacific Anti-Cancer Injectable Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Anti-Cancer Injectable Revenue and Market Share by Region (2012-2017)

3 China Anti-Cancer Injectable (Volume, Value and Sales Price)
3.1 China Anti-Cancer Injectable Sales and Value (2012-2017)
3.1.1 China Anti-Cancer Injectable Sales Volume and Growth Rate (2012-2017)
3.1.2 China Anti-Cancer Injectable Revenue and Growth Rate (2012-2017)
3.1.3 China Anti-Cancer Injectable Sales Price Trend (2012-2017)
3.2 China Anti-Cancer Injectable Sales Volume and Market Share by Type
3.3 China Anti-Cancer Injectable Sales Volume and Market Share by Application

4 Japan Anti-Cancer Injectable (Volume, Value and Sales Price)
4.1 Japan Anti-Cancer Injectable Sales and Value (2012-2017)
4.1.1 Japan Anti-Cancer Injectable Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Anti-Cancer Injectable Revenue and Growth Rate (2012-2017)
4.1.3 Japan Anti-Cancer Injectable Sales Price Trend (2012-2017)
4.2 Japan Anti-Cancer Injectable Sales Volume and Market Share by Type
4.3 Japan Anti-Cancer Injectable Sales Volume and Market Share by Application

5 South Korea Anti-Cancer Injectable (Volume, Value and Sales Price)
5.1 South Korea Anti-Cancer Injectable Sales and Value (2012-2017)
5.1.1 South Korea Anti-Cancer Injectable Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Anti-Cancer Injectable Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Anti-Cancer Injectable Sales Price Trend (2012-2017)
5.2 South Korea Anti-Cancer Injectable Sales Volume and Market Share by Type
5.3 South Korea Anti-Cancer Injectable Sales Volume and Market Share by Application

6 Taiwan Anti-Cancer Injectable (Volume, Value and Sales Price)
6.1 Taiwan Anti-Cancer Injectable Sales and Value (2012-2017)
6.1.1 Taiwan Anti-Cancer Injectable Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Anti-Cancer Injectable Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Anti-Cancer Injectable Sales Price Trend (2012-2017)
6.2 Taiwan Anti-Cancer Injectable Sales Volume and Market Share by Type
6.3 Taiwan Anti-Cancer Injectable Sales Volume and Market Share by Application

7 India Anti-Cancer Injectable (Volume, Value and Sales Price)
7.1 India Anti-Cancer Injectable Sales and Value (2012-2017)
7.1.1 India Anti-Cancer Injectable Sales Volume and Growth Rate (2012-2017)
7.1.2 India Anti-Cancer Injectable Revenue and Growth Rate (2012-2017)
7.1.3 India Anti-Cancer Injectable Sales Price Trend (2012-2017)
7.2 India Anti-Cancer Injectable Sales Volume and Market Share by Type
7.3 India Anti-Cancer Injectable Sales Volume and Market Share by Application

8 Southeast Asia Anti-Cancer Injectable (Volume, Value and Sales Price)
8.1 Southeast Asia Anti-Cancer Injectable Sales and Value (2012-2017)
8.1.1 Southeast Asia Anti-Cancer Injectable Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Anti-Cancer Injectable Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Anti-Cancer Injectable Sales Price Trend (2012-2017)
8.2 Southeast Asia Anti-Cancer Injectable Sales Volume and Market Share by Type
8.3 Southeast Asia Anti-Cancer Injectable Sales Volume and Market Share by Application

9 Australia Anti-Cancer Injectable (Volume, Value and Sales Price)
9.1 Australia Anti-Cancer Injectable Sales and Value (2012-2017)
9.1.1 Australia Anti-Cancer Injectable Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Anti-Cancer Injectable Revenue and Growth Rate (2012-2017)
9.1.3 Australia Anti-Cancer Injectable Sales Price Trend (2012-2017)
9.2 Australia Anti-Cancer Injectable Sales Volume and Market Share by Type
9.3 Australia Anti-Cancer Injectable Sales Volume and Market Share by Application

10 Asia-Pacific Anti-Cancer Injectable Players/Suppliers Profiles and Sales Data
10.1 Eli Lilly
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Anti-Cancer Injectable Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Eli Lilly Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Chiron
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Anti-Cancer Injectable Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Chiron Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Celgene Inc
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Anti-Cancer Injectable Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Celgene Inc Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Ferring Pharmaceuticals
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Anti-Cancer Injectable Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Ferring Pharmaceuticals Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Johnson & Johnson
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Anti-Cancer Injectable Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Johnson & Johnson Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Jazz Pharmaceuticals
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Anti-Cancer Injectable Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Jazz Pharmaceuticals Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Spectrum Pharmaceuticals
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Anti-Cancer Injectable Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Spectrum Pharmaceuticals Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Takeda Pharmaceuticals
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Anti-Cancer Injectable Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Takeda Pharmaceuticals Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Genzyme
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Anti-Cancer Injectable Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Genzyme Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 GSK
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Anti-Cancer Injectable Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 GSK Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Sandoz
10.12 Pharmascience
10.13 Admac Lifesciences
10.14 Fresenius Kabi Oncology Limited
10.15 Jiangsu Hengrui Medicine
10.16 Nanjing Cisco Pharmaceuticals
10.17 Jiangsu Hengrui Medicine
10.18 Shanghai Roche
10.19 Jiangsu Haosen Pharmaceutical
10.20 F Hoffmann-La Roche Ltd (SW)
10.21 France Masi Pu (China) Pharmaceuticals

11 Anti-Cancer Injectable Manufacturing Cost Analysis
11.1 Anti-Cancer Injectable Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Anti-Cancer Injectable

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Anti-Cancer Injectable Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Anti-Cancer Injectable Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Anti-Cancer Injectable Market Forecast (2017-2022)
15.1 Asia-Pacific Anti-Cancer Injectable Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Anti-Cancer Injectable Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Anti-Cancer Injectable Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Anti-Cancer Injectable Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Anti-Cancer Injectable Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Anti-Cancer Injectable Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Anti-Cancer Injectable Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Anti-Cancer Injectable Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Anti-Cancer Injectable Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Anti-Cancer Injectable Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Anti-Cancer Injectable Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Anti-Cancer Injectable Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Anti-Cancer Injectable Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Anti-Cancer Injectable Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Anti-Cancer Injectable Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Anti-Cancer Injectable Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Anti-Cancer Injectable Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Anti-Cancer Injectable Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Anti-Cancer Injectable Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Anti-Cancer Injectable
Figure Asia-Pacific Anti-Cancer Injectable Sales Volume (Million Units) by Type (2012-2022)
Figure Asia-Pacific Anti-Cancer Injectable Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemical Medicine Injectable Product Picture
Figure Traditional Chinese Medicine Injectable Product Picture
Figure Asia-Pacific Anti-Cancer Injectable Sales (Million Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Anti-Cancer Injectable by Application in 2016
Figure Hospital Examples
Figure Clinic Examples
Figure Other Examples
Figure Asia-Pacific Anti-Cancer Injectable Market Size (Million USD) by Region (2012-2022)
Figure China Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Anti-Cancer Injectable Sales Volume (Million Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Anti-Cancer Injectable Market Major Players Product Sales Volume (Million Units)(2012-2017)
Table Asia-Pacific Anti-Cancer Injectable Sales (Million Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Anti-Cancer Injectable Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Anti-Cancer Injectable Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Anti-Cancer Injectable Sales Share by Players/Suppliers
Figure Asia-Pacific Anti-Cancer Injectable Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Anti-Cancer Injectable Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Anti-Cancer Injectable Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Anti-Cancer Injectable Revenue Share by Players
Figure 2017 Asia-Pacific Anti-Cancer Injectable Revenue Share by Players
Table Asia-Pacific Anti-Cancer Injectable Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Anti-Cancer Injectable Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-Cancer Injectable by Type (2012-2017)
Figure Asia-Pacific Anti-Cancer Injectable Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Anti-Cancer Injectable Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Anti-Cancer Injectable Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Cancer Injectable by Type (2012-2017)
Figure Asia-Pacific Anti-Cancer Injectable Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Anti-Cancer Injectable Sales Volume (Million Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Anti-Cancer Injectable Sales Share by Region (2012-2017)
Figure Sales Market Share of Anti-Cancer Injectable by Region (2012-2017)
Figure Asia-Pacific Anti-Cancer Injectable Sales Market Share by Region in 2016
Table Asia-Pacific Anti-Cancer Injectable Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Anti-Cancer Injectable Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Anti-Cancer Injectable by Region (2012-2017)
Figure Asia-Pacific Anti-Cancer Injectable Revenue Market Share by Region in 2016
Table Asia-Pacific Anti-Cancer Injectable Sales Volume (Million Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Anti-Cancer Injectable Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Anti-Cancer Injectable Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Anti-Cancer Injectable Sales Market Share by Application (2012-2017)
Figure China Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure China Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Anti-Cancer Injectable Sales Price (USD/Unit) Trend (2012-2017)
Table China Anti-Cancer Injectable Sales Volume (Million Units) by Type (2012-2017)
Table China Anti-Cancer Injectable Sales Volume Market Share by Type (2012-2017)
Figure China Anti-Cancer Injectable Sales Volume Market Share by Type in 2016
Table China Anti-Cancer Injectable Sales Volume (Million Units) by Applications (2012-2017)
Table China Anti-Cancer Injectable Sales Volume Market Share by Application (2012-2017)
Figure China Anti-Cancer Injectable Sales Volume Market Share by Application in 2016
Figure Japan Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Japan Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Anti-Cancer Injectable Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Anti-Cancer Injectable Sales Volume (Million Units) by Type (2012-2017)
Table Japan Anti-Cancer Injectable Sales Volume Market Share by Type (2012-2017)
Figure Japan Anti-Cancer Injectable Sales Volume Market Share by Type in 2016
Table Japan Anti-Cancer Injectable Sales Volume (Million Units) by Applications (2012-2017)
Table Japan Anti-Cancer Injectable Sales Volume Market Share by Application (2012-2017)
Figure Japan Anti-Cancer Injectable Sales Volume Market Share by Application in 2016
Figure South Korea Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure South Korea Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Anti-Cancer Injectable Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Anti-Cancer Injectable Sales Volume (Million Units) by Type (2012-2017)
Table South Korea Anti-Cancer Injectable Sales Volume Market Share by Type (2012-2017)
Figure South Korea Anti-Cancer Injectable Sales Volume Market Share by Type in 2016
Table South Korea Anti-Cancer Injectable Sales Volume (Million Units) by Applications (2012-2017)
Table South Korea Anti-Cancer Injectable Sales Volume Market Share by Application (2012-2017)
Figure South Korea Anti-Cancer Injectable Sales Volume Market Share by Application in 2016
Figure Taiwan Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Taiwan Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Anti-Cancer Injectable Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Anti-Cancer Injectable Sales Volume (Million Units) by Type (2012-2017)
Table Taiwan Anti-Cancer Injectable Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Anti-Cancer Injectable Sales Volume Market Share by Type in 2016
Table Taiwan Anti-Cancer Injectable Sales Volume (Million Units) by Applications (2012-2017)
Table Taiwan Anti-Cancer Injectable Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Anti-Cancer Injectable Sales Volume Market Share by Application in 2016
Figure India Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure India Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Anti-Cancer Injectable Sales Price (USD/Unit) Trend (2012-2017)
Table India Anti-Cancer Injectable Sales Volume (Million Units) by Type (2012-2017)
Table India Anti-Cancer Injectable Sales Volume Market Share by Type (2012-2017)
Figure India Anti-Cancer Injectable Sales Volume Market Share by Type in 2016
Table India Anti-Cancer Injectable Sales Volume (Million Units) by Application (2012-2017)
Table India Anti-Cancer Injectable Sales Volume Market Share by Application (2012-2017)
Figure India Anti-Cancer Injectable Sales Volume Market Share by Application in 2016
Figure Southeast Asia Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Southeast Asia Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Anti-Cancer Injectable Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Anti-Cancer Injectable Sales Volume (Million Units) by Type (2012-2017)
Table Southeast Asia Anti-Cancer Injectable Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Anti-Cancer Injectable Sales Volume Market Share by Type in 2016
Table Southeast Asia Anti-Cancer Injectable Sales Volume (Million Units) by Applications (2012-2017)
Table Southeast Asia Anti-Cancer Injectable Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Anti-Cancer Injectable Sales Volume Market Share by Application in 2016
Figure Australia Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Australia Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Anti-Cancer Injectable Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Anti-Cancer Injectable Sales Volume (Million Units) by Type (2012-2017)
Table Australia Anti-Cancer Injectable Sales Volume Market Share by Type (2012-2017)
Figure Australia Anti-Cancer Injectable Sales Volume Market Share by Type in 2016
Table Australia Anti-Cancer Injectable Sales Volume (Million Units) by Applications (2012-2017)
Table Australia Anti-Cancer Injectable Sales Volume Market Share by Application (2012-2017)
Figure Australia Anti-Cancer Injectable Sales Volume Market Share by Application in 2016
Table Eli Lilly Anti-Cancer Injectable Basic Information List
Table Eli Lilly Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Eli Lilly Anti-Cancer Injectable Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly Anti-Cancer Injectable Revenue Market Share in Asia-Pacific (2012-2017)
Table Chiron Anti-Cancer Injectable Basic Information List
Table Chiron Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Chiron Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Chiron Anti-Cancer Injectable Sales Market Share in Asia-Pacific (2012-2017)
Figure Chiron Anti-Cancer Injectable Revenue Market Share in Asia-Pacific (2012-2017)
Table Celgene Inc Anti-Cancer Injectable Basic Information List
Table Celgene Inc Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Inc Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Celgene Inc Anti-Cancer Injectable Sales Market Share in Asia-Pacific (2012-2017)
Figure Celgene Inc Anti-Cancer Injectable Revenue Market Share in Asia-Pacific (2012-2017)
Table Ferring Pharmaceuticals Anti-Cancer Injectable Basic Information List
Table Ferring Pharmaceuticals Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ferring Pharmaceuticals Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Ferring Pharmaceuticals Anti-Cancer Injectable Sales Market Share in Asia-Pacific (2012-2017)
Figure Ferring Pharmaceuticals Anti-Cancer Injectable Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Anti-Cancer Injectable Basic Information List
Table Johnson & Johnson Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Anti-Cancer Injectable Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Anti-Cancer Injectable Revenue Market Share in Asia-Pacific (2012-2017)
Table Jazz Pharmaceuticals Anti-Cancer Injectable Basic Information List
Table Jazz Pharmaceuticals Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Jazz Pharmaceuticals Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Jazz Pharmaceuticals Anti-Cancer Injectable Sales Market Share in Asia-Pacific (2012-2017)
Figure Jazz Pharmaceuticals Anti-Cancer Injectable Revenue Market Share in Asia-Pacific (2012-2017)
Table Spectrum Pharmaceuticals Anti-Cancer Injectable Basic Information List
Table Spectrum Pharmaceuticals Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Spectrum Pharmaceuticals Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Spectrum Pharmaceuticals Anti-Cancer Injectable Sales Market Share in Asia-Pacific (2012-2017)
Figure Spectrum Pharmaceuticals Anti-Cancer Injectable Revenue Market Share in Asia-Pacific (2012-2017)
Table Takeda Pharmaceuticals Anti-Cancer Injectable Basic Information List
Table Takeda Pharmaceuticals Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceuticals Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Takeda Pharmaceuticals Anti-Cancer Injectable Sales Market Share in Asia-Pacific (2012-2017)
Figure Takeda Pharmaceuticals Anti-Cancer Injectable Revenue Market Share in Asia-Pacific (2012-2017)
Table Genzyme Anti-Cancer Injectable Basic Information List
Table Genzyme Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genzyme Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure Genzyme Anti-Cancer Injectable Sales Market Share in Asia-Pacific (2012-2017)
Figure Genzyme Anti-Cancer Injectable Revenue Market Share in Asia-Pacific (2012-2017)
Table GSK Anti-Cancer Injectable Basic Information List
Table GSK Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2017)
Figure GSK Anti-Cancer Injectable Sales Market Share in Asia-Pacific (2012-2017)
Figure GSK Anti-Cancer Injectable Revenue Market Share in Asia-Pacific (2012-2017)
Table Sandoz Anti-Cancer Injectable Basic Information List
Table Pharmascience Anti-Cancer Injectable Basic Information List
Table Admac Lifesciences Anti-Cancer Injectable Basic Information List
Table Fresenius Kabi Oncology Limited Anti-Cancer Injectable Basic Information List
Table Jiangsu Hengrui Medicine Anti-Cancer Injectable Basic Information List
Table Nanjing Cisco Pharmaceuticals Anti-Cancer Injectable Basic Information List
Table Jiangsu Hengrui Medicine Anti-Cancer Injectable Basic Information List
Table Shanghai Roche Anti-Cancer Injectable Basic Information List
Table Jiangsu Haosen Pharmaceutical Anti-Cancer Injectable Basic Information List
Table F Hoffmann-La Roche Ltd (SW) Anti-Cancer Injectable Basic Information List
Table France Masi Pu (China) Pharmaceuticals Anti-Cancer Injectable Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Cancer Injectable
Figure Manufacturing Process Analysis of Anti-Cancer Injectable
Figure Anti-Cancer Injectable Industrial Chain Analysis
Table Raw Materials Sources of Anti-Cancer Injectable Major Manufacturers in 2016
Table Major Buyers of Anti-Cancer Injectable
Table Distributors/Traders List
Figure Asia-Pacific Anti-Cancer Injectable Sales Volume (Million Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Anti-Cancer Injectable Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Anti-Cancer Injectable Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Anti-Cancer Injectable Sales Volume (Million Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-Cancer Injectable Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-Cancer Injectable Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Anti-Cancer Injectable Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-Cancer Injectable Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-Cancer Injectable Revenue Market Share Forecast by Region in 2022
Figure China Anti-Cancer Injectable Sales (Million Units) and Growth Rate Forecast (2017-2022)
Figure China Anti-Cancer Injectable Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Anti-Cancer Injectable Sales (Million Units) and Growth Rate Forecast (2017-2022)
Figure Japan Anti-Cancer Injectable Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Anti-Cancer Injectable Sales (Million Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Anti-Cancer Injectable Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Anti-Cancer Injectable Sales (Million Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Anti-Cancer Injectable Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Anti-Cancer Injectable Sales (Million Units) and Growth Rate Forecast (2017-2022)
Figure India Anti-Cancer Injectable Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Anti-Cancer Injectable Sales (Million Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Anti-Cancer Injectable Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Anti-Cancer Injectable Sales (Million Units) and Growth Rate Forecast (2017-2022)
Figure Australia Anti-Cancer Injectable Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Anti-Cancer Injectable Sales (Million Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Anti-Cancer Injectable Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Anti-Cancer Injectable Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Anti-Cancer Injectable Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Anti-Cancer Injectable Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Anti-Cancer Injectable Sales (Million Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Anti-Cancer Injectable Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *